|
1
|
Luzuriaga K and Sullivan JL: Infectious
mononucleosis. N Engl J Med. 362:1993–2000. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vouloumanou EK, Rafailidis PI and Falagas
ME: Current diagnosis and management of infectious mononucleosis.
Curr Opin Hematol. 19:14–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lennon P, O'Neill JP, Fenton JE and
O'Dwyer T: Challenging the use of the lymphocyte to white cell
count ratio in the diagnosis of infectious mononucleosis by
analysis of a large cohort of monospot test results. Clin
Otolaryngol. 35:397–401. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Henle G, Henle W and Diehl V: Relation of
Burkitt's tumor-associated herpes-ytpe virus to infectious
mononucleosis. Proc Natl Acad Sci USA. 59:pp. 94–101. 1968,
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Q, Lou S, Meng Z and Ren X: Gender
and age impacts on the correlations between hyperuricemia and
metabolic syndrome in Chinese. Clin Rheumatol. 30:777–787. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang J, Meng Z, Zhang Q, Liu L, Song K,
Tan J, Li X, Jia Q, Zhang G and He Y: Gender impact on the
correlations between subclinical thyroid dysfunction and
hyperuricemia in Chinese. Clin Rheumatol. 35:143–149. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Lou S, Xu K, Meng Z, Zhang Q and
Song K: Relationship between lifestyle choices and hyperuricemia in
Chinese men and women. Clin Rheumatol. 32:233–239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Llull L, Amaro S and Chamorro Á:
Administration of uric acid in the emergency treatment of acute
ischemic stroke. Curr Neurol Neurosci Rep. 16:42016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Lin Y, Liu Y, Chen Y, Wang B, Li
C, Yan S, Wang Y and Zhao W: Serum uric acid levels and outcomes
after acute ischemic stroke. Mol Neurobiol. 53:1753–1759. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Huang ZC, Lu TS, You SJ, Cao YJ
and Liu CF: Prognostic significance of uric acid levels in ischemic
stroke patients. Neurotox Res. 29:10–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu B, Shen Y, Xiao K, Tang Y, Cen L and
Wei J: Serum uric acid levels in patients with multiple sclerosis:
A meta-analysis. Neurol Res. 34:163–171. 2012.PubMed/NCBI
|
|
12
|
Moccia M, Lanzillo R, Costabile T, Russo
C, Carotenuto A, Sasso G, Postiglione E, De Luca Picione C, Vastola
M, Maniscalco GT, et al: Uric acid in relapsing-remitting multiple
sclerosis: A 2-year longitudinal study. J Neurol. 262:961–967.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Li M, Wang X, Yi H, Xu L, Zhong XF
and Peng FH: Serum uric acid levels in patients with infections of
central nervous system. Acta Neurol Belg. 116:303–308. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Collazos J, Blanco MS, Guerra E, Mayo J
and Martínez E: Sequential evaluation of serum urate concentrations
in AIDS patients with infections of the central nervous system.
Clin Chem Lab Med. 38:1293–1296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morato-Conceicao YT, Alves-Junior ER,
Arruda TA, Lopes JC and Fontes CJ: Serum uric acid levels during
leprosy reaction episodes. PeerJ. 4:e17992016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dylewski JS and Gerson M: Hyperuricemia in
patients with infectious mononucleosis. Can Med Assoc J.
132:1169–1170. 1985.PubMed/NCBI
|
|
17
|
Cowdrey SC: Hyperuricemia in infectious
mononucleosis. JAMA. 196:319–321. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cowdrey SC: Hyperuricemia in infectious
mononucleosis: Further observations. J Am Coll Health Assoc.
18:382–383. 1970.PubMed/NCBI
|
|
19
|
Sugita K, Hagisawa S, Satoh Y, Eguchi M
and Furukawa T: Recurrent hepatosplenomegaly and peripheral blood
cytopenia, persistent epstein-barr virus infection and central
nervous system manifestation in a patient with lymphadenopathy and
low serum uric acid. Acta Paediatr Jpn. 40:362–366. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moccia M, Lanzillo R, Palladino R, Russo
C, Carotenuto A, Massarelli M, Vacca G, Vacchiano V, Nardone A,
Triassi M and Morra VB: Uric acid: A potential biomarker of
multiple sclerosis and of its disability. Clin Chem Lab Med.
53:753–759. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu XW, Muzny DM, Lee CC and Caskey CT: Two
independent mutational events in the loss of urate oxidase during
hominoid evolution. J Mol Evol. 34:78–84. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Santos CX, Anjos EI and Augusto O: Uric
acid oxidation by peroxynitrite: Multiple reactions, free radical
formation and amplification of lipid oxidation. Arch Biochem
Biophys. 372:285–294. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Becker BF: Towards the physiological
function of uric acid. Free Radic Biol Med. 14:615–631. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Messerli FH, Makani H and Halpern D: Gout.
N Engl J Med. 364:1876–1877. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neogi T: Clinical practice. gout. N Engl J
Med. 364:443–452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanellis J and Kang DH: Uric acid as a
mediator of endothelial dysfunction, inflammation and vascular
disease. Semin Nephrol. 25:39–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sautin YY and Johnson RJ: Uric acid: The
oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids.
27:608–619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Proctor PH: Uric acid: Neuroprotective or
neurotoxic? Stroke. 39:e882008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dawson J, Quinn T, Lees K and Walters M:
The continued yin and yang of uric acid. Stroke. 39:e92008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Proctor PH: Uric acid and neuroprotection.
Stroke. 39:e1262008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lipton P: Ischemic cell death in brain
neurons. Physiol Rev. 79:1431–1568. 1999.PubMed/NCBI
|
|
32
|
Amaro S, Soy D, Obach V, Cervera A, Planas
AM and Chamorro A: A pilot study of dual treatment with recombinant
tissue plasminogen activator and uric acid in acute ischemic
stroke. Stroke. 38:2173–2175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brouns R, Wauters A, Van De Vijver G, De
Surgeloose D, Sheorajpanday R and De Deyn PP: Decrease in uric acid
in acute ischemic stroke correlates with stroke severity, evolution
and outcome. Clin Chem Lab Med. 48:383–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Onetti Y, Dantas AP, Pérez B, Cugota R,
Chamorro A, Planas AM, Vila E and Jiménez-Altayó F: Middle cerebral
artery remodeling following transient brain ischemia is linked to
early postischemic hyperemia: A target of uric acid treatment. Am J
Physiol Heart Circ Physiol. 308:H862–H874. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hooper DC, Spitsin S, Kean RB, Champion
JM, Dickson GM, Chaudhry I and Koprowski H: Uric acid, a natural
scavenger of peroxynitrite, in experimental allergic
encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA.
95:pp. 675–680. 1998, View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nudelman Y and Tunkel AR: Bacterial
meningitis: Epidemiology, pathogenesis and management update.
Drugs. 69:2577–2596. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liechti FD, Grandgirard D and Leib SL:
Bacterial meningitis: Insights into pathogenesis and evaluation of
new treatment options: A perspective from experimental studies.
Future Microbiol. 10:1195–1213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Aycicek A, Iscan A, Erel O, Akcali M and
Ocak AR: Oxidant and antioxidant parameters in the treatment of
meningitis. Pediatr Neurol. 37:117–120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Checconi P, Salzano S, Bowler L, Mullen L,
Mengozzi M, Hanschmann EM, Lillig CH, Sgarbanti R, Panella S,
Nencioni L, et al: Redox proteomics of the inflammatory secretome
identifies a common set of redoxins and other glutathionylated
proteins released in inflammation, influenza virus infection and
oxidative stress. PLoS One. 10:e01270862015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zuwała-Jagiełło J, Warwas M and
Pazgan-Simon M: Ischemia-modified albumin (IMA) is increased in
patients with chronic hepatitis C infection and related to markers
of oxidative stress and inflammation. Acta Biochim Pol. 59:661–667.
2012.PubMed/NCBI
|
|
41
|
Komaravelli N and Casola A: Respiratory
Viral Infections and subversion of cellular antioxidant defenses. J
Pharmacogenomics Pharmacoproteomics. 5:10001412014.PubMed/NCBI
|
|
42
|
Ngondi JL, Oben J, Forkah DM, Etame LH and
Mbanya D: The effect of different combination therapies on
oxidative stress markers in HIV infected patients in Cameroon. AIDS
Res Ther. 3:192006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chakraborty SP, Das S, Chattopadhyay S,
Tripathy S, Dash SK, Pramanik P and Roy S: Staphylococcus
aureus infection induced redox signaling and DNA fragmentation
in T-lymphocytes: Possible ameliorative role of nanoconjugated
vancomycin. Toxicol Mech Methods. 22:193–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Aslan M, Nazligul Y, Horoz M, Bolukbas C,
Bolukbas FF, Aksoy N, Celik H and Erel O: Serum prolidase activity
and oxidative status in Helicobacter pylori infection. Clin
Biochem. 40:37–40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hébert-Schuster M, Borderie D, Grange PA,
Lemarechal H, Kavian-Tessler N, Batteux F and Dupin N: Oxidative
stress markers are increased since early stages of infection in
syphilitic patients. Arch Dermatol Res. 304:689–697. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kariya C, Chu HW, Huang J, Leitner H,
Martin RJ and Day BJ: Mycoplasma pneumoniae infection and
environmental tobacco smoke inhibit lung glutathione adaptive
responses and increase oxidative stress. Infect Immun.
76:4455–4462. 2008. View Article : Google Scholar : PubMed/NCBI
|
